Skip to main content
. 2001 Aug;45(8):2263–2268. doi: 10.1128/AAC.45.8.2263-2268.2001

TABLE 3.

Inhibitory effects of quinolones against type II topoisomerases

Compound IC50 (μg/ml) for:
DNA gyrase
Topoisomerase IV
Wild type T83I Wild type S87L
Levofloxacin 0.88 10.4 4.96 49.2
Sitafloxacin 0.42 1.85 2.12 8.62
Ciprofloxacin 0.55 8.29 4.06 33.0
Sparfloxacin 0.75 17.5 6.14 52.3